| CDW quote reference | $147.81 close on July 31, 2026 | StockAnalysis.com CDW quote | August 2, 2026 |
| Market capitalization verification | $18.88 billion calculated as $147.81 x 127.75 million shares | financial_rigor.py market cap verification and StockAnalysis share data | August 2, 2026 |
| Shares outstanding | 127.75 million shares, down 2.58% year over year | StockAnalysis.com CDW statistics | August 1, 2026 |
| Q1 2026 results | Net sales $5.6798 billion up 9.2%, net income $235.4 million up 4.7%, diluted EPS $1.82, non-GAAP EPS $2.28 | CDW Q1 2026 earnings release | August 2, 2026 |
| Q1 2026 segment growth | Commercial +9.6% to $3.569 billion, Government +4.6% to $633 million, Education +2.5% to $675 million, Other +17.9% to $803 million | CDW Q1 2026 earnings release | August 2, 2026 |
| Q1 2026 margin | Gross profit margin 21.0% versus 21.6% a year earlier, operating margin 6.6%, non-GAAP operating margin 8.0% | CDW Q1 2026 earnings release | August 2, 2026 |
| Cash and debt at March 31, 2026 | $578.6 million cash, $5.641 billion total debt, $5.062 billion net debt, and $1.887 billion revolver availability | CDW Q1 2026 balance sheet | August 2, 2026 |
| Trailing twelve month financials | Revenue $22.905 billion up 7.4%, net income $1.077 billion, EPS $8.22, operating cash flow $1.193 billion, free cash flow $1.076 billion | StockAnalysis.com CDW financials | August 1, 2026 |
| FY2025 revenue and net income | Net sales $22.424 billion up 6.8%, net income $1.067 billion down 1.0%, free cash flow $920.35 million | CDW FY2025 earnings release and StockAnalysis.com financials | August 1, 2026 |
| Valuation ratios | 17.98x trailing PE, 13.49x forward PE, 0.82x sales, 7.41x book, 17.55x free cash flow, 1.70% dividend yield | financial_rigor.py valuation verification and StockAnalysis.com statistics | August 1, 2026 |
| Analyst consensus | Buy with an average target of $152.56 across 10 analysts, low $123 and high $175, median $150 | StockAnalysis.com forecast and analyst ratings | July 22, 2026 |
| Analyst rating mix, July 2026 | 5 Strong Buy, 2 Buy, 3 Hold, 0 Sell, 0 Strong Sell out of 10 analysts | StockAnalysis.com forecast recommendation trends | July 22, 2026 |
| Recent analyst target actions | J.P. Morgan maintains Buy at $175, UBS maintains Buy at $147, Citi raised $123 to $145, Morgan Stanley upgraded to Overweight at $170, Barclays reiterates $123 | StockAnalysis.com latest forecasts and TipRanks | July 22, 2026 |
| 2026 consensus estimates | FY2026 revenue estimate $23.57 billion with adjusted EPS $10.76, FY2027 revenue $24.39 billion with adjusted EPS $11.78 | StockAnalysis.com forecast financial forecast | July 22, 2026 |
| Dividend and capital returns | Quarterly dividend of $0.630 per share, $2.52 annual, 30.7% payout, buyback yield 2.58%, shareholder yield 4.29% | StockAnalysis.com dividends and statistics | August 1, 2026 |
| Short interest | 9.78 million shares short, 7.66% of shares outstanding, 4.83 days to cover | StockAnalysis.com statistics short selling | August 1, 2026 |
| Technical snapshot | 20-day MA near $137.74, 50-day MA near $132.13, 100-day MA near $127.15, 200-day MA near $132.82, RSI near 64.15, ATR near $5.53 | Barchart and StockAnalysis.com technical snapshots | July 31, 2026 |
| Company business description | Multi-brand provider of IT solutions to business, government, education, and healthcare customers in the United States, the United Kingdom, and Canada | CDW Investor Relations overview | August 2, 2026 |